This inventor holds 7 USPTO granted patents and 9 published patent applications and 2 EPO patents. Top assignees: Sumitomo Pharma Oncology, Inc., Sumitomo Dainippon Pharma Oncology, Inc.. Active years: 2021-2024.
Company Filing History:
4 out of 11 
3 out of 11 Years Active: 2021-2024
Title: Paul Flynn: Innovator in Cancer Treatment
Introduction
Paul Flynn is a notable inventor based in Citrus Heights, CA (US). He has made significant contributions to the field of oncology through his innovative work on CDK9 inhibitors. With a total of 7 patents, Flynn's research focuses on developing new agents for the treatment of cancer.
Latest Patents
Flynn's latest patents include groundbreaking work on CDK9 inhibitors and polymorphs thereof. These patents describe a crystalline form and/or polymorph of a compound that has the potential to be used as agents for cancer treatment. The patents detail methods associated with the preparation and use of these polymorphs, as well as pharmaceutical compositions that incorporate them. Additionally, they provide methods for preparing a compound with a specific formula, including its salt, tautomer, or zwitterionic forms.
Career Highlights
Throughout his career, Paul Flynn has worked with prominent companies in the pharmaceutical industry. He has been associated with Sumitomo Pharma Oncology, Inc. and Sumitomo Dainippon Pharma Oncology, Inc., where he has contributed to the development of innovative cancer therapies. His work has been instrumental in advancing the understanding and treatment of cancer.
Collaborations
Flynn has collaborated with talented individuals in his field, including Adam Siddiqui-Jain and Yuka Arikawa. These collaborations have further enhanced his research and development efforts in oncology.
Conclusion
Paul Flynn's contributions to cancer treatment through his innovative patents and collaborations highlight his dedication to improving patient outcomes. His work continues to influence the field of oncology and represents a significant advancement in cancer therapy.